376 related articles for article (PubMed ID: 26728869)
41. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
[TBL] [Abstract][Full Text] [Related]
42. Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
Chicano M; Carbonell D; Suárez-González J; Lois S; Ballesteros-Culebras M; Andrés-Zayas C; Muñiz P; Rodríguez-Macias G; Bastos-Oreiro M; Font P; Ballesteros M; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203905
[TBL] [Abstract][Full Text] [Related]
43. DL-CNV: A deep learning method for identifying copy number variations based on next generation target sequencing.
Zhang YX; Jin LC; Wang B; Hu H; Wang LQ; Li P; Zhang JL; Han K; Tian G; Yuan DW; Yang JL; Tan W; Xing XM; Lang JD
Math Biosci Eng; 2019 Sep; 17(1):202-215. PubMed ID: 31731347
[TBL] [Abstract][Full Text] [Related]
44. Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing.
Mancini-DiNardo D; Judkins T; Kidd J; Bernhisel R; Daniels C; Brown K; Meek K; Craft J; Holladay J; Morris B; Roa BB
BMC Med Genomics; 2019 Oct; 12(1):138. PubMed ID: 31623605
[TBL] [Abstract][Full Text] [Related]
45. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors.
Mukherjee S; Ma Z; Wheeler S; Sathanoori M; Coldren C; Prescott JL; Kozyr N; Bouzyk M; Correll M; Ho H; Chandra PK; Lennon PA
Cancer Genet; 2016 Apr; 209(4):119-29. PubMed ID: 26880400
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic yield of targeted next generation sequencing in 2002 Dutch cardiomyopathy patients.
Alimohamed MZ; Johansson LF; Posafalvi A; Boven LG; van Dijk KK; Walters L; Vos YJ; Westers H; Hoedemaekers YM; Sinke RJ; Sijmons RH; Sikkema-Raddatz B; Jongbloed JDH; van der Zwaag PA
Int J Cardiol; 2021 Jun; 332():99-104. PubMed ID: 33662488
[TBL] [Abstract][Full Text] [Related]
48. Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol.
Bolli N; Manes N; McKerrell T; Chi J; Park N; Gundem G; Quail MA; Sathiaseelan V; Herman B; Crawley C; Craig JI; Conte N; Grove C; Papaemmanuil E; Campbell PJ; Varela I; Costeas P; Vassiliou GS
Haematologica; 2015 Feb; 100(2):214-22. PubMed ID: 25381129
[TBL] [Abstract][Full Text] [Related]
49. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
Mack EKM; Marquardt A; Langer D; Ross P; Ultsch A; Kiehl MG; Mack HID; Haferlach T; Neubauer A; Brendel C
Haematologica; 2019 Feb; 104(2):277-287. PubMed ID: 30190345
[TBL] [Abstract][Full Text] [Related]
51. Clinical application of targeted next-generation sequencing in fetuses with congenital heart defect.
Hu P; Qiao F; Wang Y; Meng L; Ji X; Luo C; Xu T; Zhou R; Zhang J; Yu B; Wang L; Wang T; Pan Q; Ma D; Liang D; Xu Z
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):205-211. PubMed ID: 29536580
[TBL] [Abstract][Full Text] [Related]
52. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
53. Copy number variant analysis using genome-wide mate-pair sequencing.
Smadbeck JB; Johnson SH; Smoley SA; Gaitatzes A; Drucker TM; Zenka RM; Kosari F; Murphy SJ; Hoppman N; Aypar U; Sukov WR; Jenkins RB; Kearney HM; Feldman AL; Vasmatzis G
Genes Chromosomes Cancer; 2018 Sep; 57(9):459-470. PubMed ID: 29726617
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation.
Hayes JL; Tzika A; Thygesen H; Berri S; Wood HM; Hewitt S; Pendlebury M; Coates A; Willoughby L; Watson CM; Rabbitts P; Roberts P; Taylor GR
Genomics; 2013 Sep; 102(3):174-81. PubMed ID: 23598253
[TBL] [Abstract][Full Text] [Related]
55. A clinical grade sequencing-based assay for CEBPA mutation testing: report of a large series of myeloid neoplasms.
Behdad A; Weigelin HC; Elenitoba-Johnson KS; Betz BL
J Mol Diagn; 2015 Jan; 17(1):76-84. PubMed ID: 25468431
[TBL] [Abstract][Full Text] [Related]
56. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.
Nagano C; Nozu K; Morisada N; Yazawa M; Ichikawa D; Numasawa K; Kourakata H; Matsumura C; Tazoe S; Tanaka R; Yamamura T; Minamikawa S; Horinouchi T; Nakanishi K; Fujimura J; Sakakibara N; Nozu Y; Ye MJ; Kaito H; Iijima K
Clin Exp Nephrol; 2018 Aug; 22(4):881-888. PubMed ID: 29372472
[TBL] [Abstract][Full Text] [Related]
57. Efficient detection of chromosome imbalances and single nucleotide variants using targeted sequencing in the clinical setting.
Villela D; Costa SS; Vianna-Morgante AM; Krepischi ACV; Rosenberg C
Eur J Med Genet; 2017 Dec; 60(12):667-674. PubMed ID: 28882788
[TBL] [Abstract][Full Text] [Related]
58. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
59. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
[TBL] [Abstract][Full Text] [Related]
60. Detection Copy Number Variants from NGS with Sparse and Smooth Constraints.
Zhang Y; Cheung YM; Xu B; Su W
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):856-867. PubMed ID: 27164604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
